H

Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627

Watchlist Manager
Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
Watchlist
Price: 4.01 CNY -4.3% Market Closed
Market Cap: 19.8B CNY
Have any thoughts about
Hubei Biocause Pharmaceutical Co Ltd?
Write Note

Hubei Biocause Pharmaceutical Co Ltd
Effect of Foreign Exchange Rates

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hubei Biocause Pharmaceutical Co Ltd
Effect of Foreign Exchange Rates Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Effect of Foreign Exchange Rates CAGR 3Y CAGR 5Y CAGR 10Y
H
Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
Effect of Foreign Exchange Rates
-ÂĄ10.9m
CAGR 3-Years
44%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
China Life Insurance Co Ltd
SSE:601628
Effect of Foreign Exchange Rates
-ÂĄ73m
CAGR 3-Years
25%
CAGR 5-Years
N/A
CAGR 10-Years
-43%
Ping An Insurance Group Co of China Ltd
SSE:601318
Effect of Foreign Exchange Rates
-ÂĄ4B
CAGR 3-Years
4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
New China Life Insurance Company Ltd
SSE:601336
Effect of Foreign Exchange Rates
ÂĄ45m
CAGR 3-Years
N/A
CAGR 5-Years
-6%
CAGR 10-Years
-1%
S
Sunshine Insurance Group Co Ltd
HKEX:6963
Effect of Foreign Exchange Rates
-ÂĄ184m
CAGR 3-Years
-35%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Hubei Biocause Pharmaceutical Co Ltd
Glance View

Market Cap
19.8B CNY
Industry
Insurance

Hubei Biocause Pharmaceutical Co., Ltd. is an investment holding company that engages in the insurance industry. The company is headquartered in Jingmen, Hubei and currently employs 2,239 full-time employees. is a China-based company principally engaged in insurance business, such as life insurance, health insurance and casualty insurance. The firm is also involved in pharmaceutical business and chemical business. The Company’s products include polypropylene and Ibuprofen. The firm distributes its products in domestic market and to overseas markets, with Central China and South China as its main markets.

Intrinsic Value
4.79 CNY
Undervaluation 16%
Intrinsic Value
Price
H

See Also

What is Hubei Biocause Pharmaceutical Co Ltd's Effect of Foreign Exchange Rates?
Effect of Foreign Exchange Rates
-10.9m CNY

Based on the financial report for Jun 30, 2024, Hubei Biocause Pharmaceutical Co Ltd's Effect of Foreign Exchange Rates amounts to -10.9m CNY.

What is Hubei Biocause Pharmaceutical Co Ltd's Effect of Foreign Exchange Rates growth rate?
Effect of Foreign Exchange Rates CAGR 3Y
44%

The average annual Effect of Foreign Exchange Rates growth rates for Hubei Biocause Pharmaceutical Co Ltd have been 44% over the past three years .

Back to Top